Galena Biopharma Inc
Change company Symbol lookup
Select an option...
GALE Galena Biopharma Inc
CUBI Customers Bancorp Inc
XETWX Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ANTH Anthera Pharmaceuticals Inc
HZO MarineMax Inc
RCON.ZY Recon Technology Ltd
XETBX Eaton Vance Tax-Managed Buy-Write Income Fund
USRI USA Recycling Industries Inc
WBAI 500.Com Ltd
HZNOF Horizon North Logistics Inc

Health Care : Biotechnology | Small Cap BlendCompany profile

Galena Biopharma, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of targeted oncology therapeutics that address major unmet medical needs. Its development portfolio is focused primarily on addressing the rapidly growing patient populations of cancer survivors by harnessing the power of the immune system to prevent cancer recurrence. The Company’s pipeline consists of multiple mid- to late-stage clinical assets, including cancer immunotherapy programs led by NeuVax (nelipepimut-S) and GALE-301. NeuVax is currently in a pivotal, Phase III clinical trial with several concurrent Phase II trials ongoing both as a single agent and in combination with other therapies. GALE-301 is in a Phase 2a clinical trial in ovarian and endometrial cancer and in a Phase 1b given sequentially with GALE-302.

Closing Price
Day's Change
-0.02 (-1.32%)
B/A Size
Day's High
Day's Low
10-day average volume:
  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    1:00p ET 11/27/15
  • Last (size)
  • 52-Wk Range
    1.10 - 2.39
  • (06/08/15 - 08/24/15)
  • 63.0%
  • Market Cap
  • Shares Outstanding
  • -0.24
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 0.4
  • 15.99
  • (% of float 11/15/15)

Latest News

November 20, 2015
7:05 am ET
Globe Newswire
November 09, 2015
4:05 pm ET
Globe Newswire
7:05 am ET
Globe Newswire
November 06, 2015
9:00 am ET
7:05 am ET
Globe Newswire
October 30, 2015
7:05 am ET
Globe Newswire
October 26, 2015
7:05 am ET
Globe Newswire
October 22, 2015
7:09 am ET
Globe Newswire
September 30, 2015
7:05 am ET
Globe Newswire
September 29, 2015
9:12 am ET
PR Newswire
September 28, 2015
7:05 am ET
Globe Newswire
September 23, 2015
9:00 am ET
PR Newswire
September 14, 2015
7:05 am ET
Globe Newswire
September 01, 2015
7:05 am ET
Globe Newswire
August 31, 2015
11:00 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2015 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by SunGard.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by , Computrade Systems, Inc.,, , and

Copyright © 2015. All rights reserved.